Ampio Pharmaceuticals Announces Initiation Of Phase II Clinical Trial Of Optina™
Ampio Pharmaceuticals, Inc. (OTC Bulletin Board: AMPE) announced the initiation of a Phase II clinical trial of Optina™ for the treatment of diabetic macular edema, an early stage of diabetic retinopathy.…
Pfizer Announces European Union Approval of a New Form of Lipitor (atorvastatin) for Use in Children
New York, July 6, 2010 (ots/PRNewswire) - Pfizer Inc. announced it has received European Commission approval of a new chewable form of Lipitor (atorvastatin calcium)…
InNexus Announces Discovery Of Novel Protein For AMD Eye Disorder - Will Bypass Needles With Topical Application
InNexus Biotechnology Inc., a drug development company commercializing the next generation of antibodies based on its groundbreaking Dynamic Cross Linking (DXL™) technology, today announced…